drug
BACLOFEN
Marketedupdated 3mo agoby Beximco Pharmaceuticals USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4indications
investigational
Multiple Sclerosis
all catalysts(2)
Trials studying BACLOFEN
- phase4Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment
- phase3A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis
- phase1Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 8, 2037
~11.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Sep 29, 2041formulationUS 11491125
- Sep 29, 2041formulationUS 11491125
- Sep 29, 2041formulationUS 11491125
- Sep 29, 2041formulationUS 11850225
- Sep 29, 2041formulationUS 11850225
- Sep 29, 2041formulationUS 11850225
- Aug 30, 2039method-of-use (U-2779)US 10610502
- Jul 29, 2039formulationUS 10792262
- Jul 29, 2039formulationUS 10792262
- Jul 29, 2039formulationUS 10792262
- Jul 29, 2039formulationUS 11654124
- Jul 29, 2039formulationUS 11654124
- Jul 29, 2039formulationUS 11654124
- Jul 29, 2039formulationUS 11931328
- Jul 29, 2039formulationUS 11931328
- Jul 29, 2039formulationUS 11931328
- Sep 29, 2037formulationUS 11324696
- Sep 8, 2037method-of-use (U-3433)US 11446246
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that